Literature DB >> 19626992

[Expression of VEGF and NGF in gliomas of human].

Jing-tao Li1, Qi Yan, Hua-lin Yu.   

Abstract

OBJECTIVE: To examine the expression of vascular endothelial cell growth factor (VEGF) and nerve growth factor (NGF) in gliomas of human, and investigate the relationship between VEGF, NGF and pathologic grading as well as tumorigenesis of gliomas.
METHODS: Immunohistochemistry (SP) and Western blot were applied to evaluate the expression of VEGF and NGF in 5 cases of normal controls and 20 cases of human gliomas.
RESULTS: VEGF and NGF were expressed in both normal brain tissues and gliomas. VEGF was observed mainly in the cytoplasm of gliomas, while NGF were occurred in both cytoplasm and nucleus of gliomas. Western blot analysis demonstrated that the expression level of VEGF and NGF was significantly higher than that in normal controls (P< 0.05), and a significant difference in vary pathologic grading gliomas was also observed.
CONCLUSION: VEGF and NGF were expressed in both the normal brain tissues and gliomas. The level of VEGF and NGF in gliomas was upregulated than that of the normal controls. The results indicate VEGF and NGF may play an important role in the tumorigenesis of gliomas, and relate to the extent of gliomas malignant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626992

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  2 in total

1.  A study of the distribution and density of the VEGFR-2 receptor on glioma microvascular endothelial cell membranes.

Authors:  Dexiang Zhou; Shengquan Zhan; Dong Zhou; Zhaojie Li; Xiaofeng Lin; Kai Tang; Hang Shu; Guangzhong Chen; Shaojian Zeng; Yingqian Cai; Xiaodan Jiang
Journal:  Cell Mol Neurobiol       Date:  2011-03-09       Impact factor: 5.046

2.  Characterizing nanoscale changes in the activity of VEGFR-2 on glioma microvascular endothelial cell membranes using atomic force microscopy.

Authors:  Dexiang Zhou; Shengquan Zhan; Dong Zhou; Peng Wang; Guangzhong Chen; Kun Qin; Xiaofeng Lin
Journal:  Exp Ther Med       Date:  2016-12-29       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.